Cardiac-specific deletion of ATPIF1 in mice prevented the switch to glycolysis in cardiac hypertrophy and protected against cardiac dysfunction during pathological remodeling after myocardial infarction. This evidence concerns the gene ATP5IF1 and cardiac hypertrophy.